“Stem Cell Research Products – Opportunities, Tools, & Technologies” is a global strategic report report that evaluates opportunities across the entire stem cell product spectrum, with emphasis on opportunities for research product development. [Read more…]
One of our most popular market reports is “Stem Cell Research Products – Opportunities, Tools, & Technologies.” It is a 175-page global strategic report that tracks traditional market metrics, which include trend rate data for stem cell clinical trials, scientific publications, grants, patents, product launches, new market entrants, acquisitions, industry deal-making, and more.
Importantly, it also tracks recently discovered social analytics, which are metrics derived from social media sites, search engines, online advertising platforms, and more. Specifically, social analytics can be collected from platforms like Twitter, LinkedIn, Facebook, Google Search, and Google Trends.
The importance of these social analytics is that they reveal both individual user behavior on a topic, as well as aggregate group activity.
The possibilities arising from stem cells have resulted in great commercial interest, with potential applications ranging from their use in the reversal of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, toxicology assessment, and more. To facilitate research resulting from interest in these potential far-ranging applications, a large and growing stem cells research products market has emerged.
One of several large companies selling stem cell research products is Lonza Group. Others competitors include Thermo Fisher Scientific, BD Biosciences, Merck KGaA, Miltenyi Biotec, STEMCELL Technologies, Clontech (a Takara Bio Company), GE Healthcare Life Sciences, and more.
In major news released today, Lonza Group from Basel, Switzerland, reported a record 1st quarter of 2016, recording its “strongest first quarter in history in terms of sales and earnings.”
Lonza has several different business divisions, including Pharma&Biotech, Specialty Ingredients, Custom Manufacturing, and more. One of these divisions is Lonza Bioscience (LBS), which develops and manufactures tools for life sciences researchers. In this April 26, 2016, press release, Lonza states: “Our healthy Bioscience Solutions business showed further improvement compared with the previous year, driven by product introductions and sound demand in all sub-segments.”
To learn more about Lonza’s role within the research products market, view “Stem Cell Research Products – Opportunities, Tools, and Technologies.
To learn more about Lonza’s record first quarter results, read the full press release issued by Lonza Group (below). [Read more…]
Although most of BioInformant’s global strategic reports provide targeted analysis for a specific stem cell type, “Stem Cell Research Products – Opportunities, Tools, and Technologies” evaluates strategies across the entire stem cell product spectrum, with emphasis on opportunities for stem cell research product development.
It explores unique market opportunities by stem cell type, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and more. [Read more…]
February 11, 2016; Washington, DC — BioInformant announces the February 2016 release of its global strategic report, “Stem Cell Research Products, Opportunities, Tools, and Technologies” with market size, segments, trends, and projections to 2020.
The first and only market research firm to specialize in the stem cell industry, BioInformant has more than a decade of historical information on all segments of the stem cell market, by stem cell type. This powerful 175 page global strategic report contains market size, segments, trends, and projections through 2020, as well a social analytics and an end-user survey of nearly 300 stem cell scientists. The “Survey of Stem Cell Scientists” identifies technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide. [Read more…]